UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 277

Sortiert nach

Dicer, Drosha, and Outcomes in Patients with Ovarian Cancer

The New England journal of medicine, 2008-12, Vol.359 (25), p.2641-2650

2008

Link zum Volltext

Verfügbarkeit prüfen

Neoadjuvant chemotherapy for low-grade serous carcinoma of the ovary or peritoneum

Gynecologic oncology, 2008-03, Vol.108 (3), p.510-514

2008

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery

Cancer research (Chicago, Ill.), 2005-08, Vol.65 (15), p.6910-6918

2005

Link zum Volltext

Verfügbarkeit prüfen

BRAF Mutation Is Rare in Advanced-Stage Low-Grade Ovarian Serous Carcinomas

The American journal of pathology, 2010-10, Vol.177 (4), p.1611-1617

2010

Link zum Volltext

Verfügbarkeit prüfen

ERG and FLI1 protein expression in epithelioid sarcoma

Modern pathology, 2014-04, Vol.27 (4), p.496-501

2014

Link zum Volltext

Verfügbarkeit prüfen

A novel platform for detection of CK+ and CK- CTCs

Cancer discovery, 2011-12, Vol.1 (7), p.580-586

2011

Link zum Volltext

Verfügbarkeit prüfen

Targeted Delivery of Small Interfering RNA Using Reconstituted High-Density Lipoprotein Nanoparticles

Neoplasia (New York, N.Y.), 2011-04, Vol.13 (4), p.309-IN8

2011

Link zum Volltext

Verfügbarkeit prüfen

Clinical behavior of stage II-IV low-grade serous carcinoma of the ovary

Obstetrics and gynecology (New York. 1953), 2006-08, Vol.108 (2), p.361-368

2006

Link zum Volltext

Verfügbarkeit prüfen

Interobserver and intraobserver variability of a two-tier system for grading ovarian serous carcinoma

The American journal of surgical pathology, 2007-08, Vol.31 (8), p.1168-1174

2007

Link zum Volltext

Verfügbarkeit prüfen

Biological Roles of the Delta Family Notch Ligand Dll4 in Tumor and Endothelial Cells in Ovarian Cancer

Cancer research (Chicago, Ill.), 2011-09, Vol.71 (18), p.6030-6039

2011

Link zum Volltext

Verfügbarkeit prüfen

Gross cystic disease fluid protein-15 and mammaglobin A expression determined by immunohistochemistry is of limited utility in triple-negative breast cancer

Histopathology, 2013-01, Vol.62 (2), p.267-274

2013

Link zum Volltext

Verfügbarkeit prüfen

Undifferentiated carcinoma of the endometrium

The American journal of surgical pathology, 2005-10, Vol.29 (10), p.1316-1321

2005

Link zum Volltext

Verfügbarkeit prüfen

HLA Class I Antigen Processing Machinery Component Expression and Intratumoral T-Cell Infiltrate as Independent Prognostic Markers in Ovarian Carcinoma

Clinical cancer research, 2008-06, Vol.14 (11), p.3372-3379

2008

Link zum Volltext

Verfügbarkeit prüfen

Immunohistochemical Studies of Trophoblastic Tumors

The American journal of surgical pathology, 2009-04, Vol.33 (4), p.633-638

2009

Link zum Volltext

Verfügbarkeit prüfen

Thyroid transcription factor-1 expression in ovarian epithelial neoplasms

Modern pathology, 2008-04, Vol.21 (4), p.485-490

2008

Link zum Volltext

Verfügbarkeit prüfen

Overexpression of the Centrosomal Protein Aurora-A Kinase is Associated with Poor Prognosis in Epithelial Ovarian Cancer Patients

Clinical cancer research, 2007-07, Vol.13 (14), p.4098-4104

2007

Link zum Volltext

Verfügbarkeit prüfen

Implementation of American Society of Clinical Oncology/College of American Pathologists HER2 Guideline Recommendations in a tertiary care facility increases HER2 immunohistochemistry and fluorescence in situ hybridization concordance and decreases the number of inconclusive cases

Archives of pathology & laboratory medicine (1976), 2009-05, Vol.133 (5), p.775-780

2009

Link zum Volltext

Verfügbarkeit prüfen

PAX2 expression in low malignant potential ovarian tumors and low-grade ovarian serous carcinomas

Modern pathology, 2009-09, Vol.22 (9), p.1243-1250

2009

Link zum Volltext

Verfügbarkeit prüfen

Galectin-7 levels predict radiation response in squamous cell carcinoma of the cervix

Gynecologic oncology, 2013-12, Vol.131 (3), p.645-649

2013

Link zum Volltext

Verfügbarkeit prüfen

The insulin-like growth factor 1 pathway is a potential therapeutic target for low-grade serous ovarian carcinoma

Gynecologic oncology, 2011-10, Vol.123 (1), p.13-18

2011

Link zum Volltext

Verfügbarkeit prüfen

Mitosis-specific marker phospho-histone H3 in the assessment of mitotic index in uterine smooth muscle tumors: a pilot study

International journal of gynecological pathology, 2009-07, Vol.28 (4), p.316

2009

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of p16 and ProExC Immunostaining in the Detection of High-Grade Cervical Intraepithelial Neoplasia and Cervical Carcinoma

American journal of clinical pathology, 2011-02, Vol.135 (2), p.212-220

2011

Link zum Volltext

Verfügbarkeit prüfen

Secondary chondrosarcoma

Journal of the American Academy of Orthopaedic Surgeons, 2010-10, Vol.18 (10), p.608

2010

Link zum Volltext

Verfügbarkeit prüfen

Genome wide DNA copy number analysis of serous type ovarian carcinomas identifies genetic markers predictive of clinical outcome

PloS one, 2012-02, Vol.7 (2), p.e30996-e30996

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 277

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(237)
Mit Volltextzugriff
(251)

Publikationsform

Sprache

Englisch
(277)
Japanisch
(45)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Dicer, Drosha, and Outcomes in Patients with Ovarian Cancer

Neoadjuvant chemotherapy for low-grade serous carcinoma of the ovary or peritoneum

Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery

A 2‐stage ovarian cancer screening strategy using the Risk of Ovarian Cancer Algorithm (ROCA) identifies early‐stage incident cancers and demonstrates high positive predictive value

BRAF Mutation Is Rare in Advanced-Stage Low-Grade Ovarian Serous Carcinomas

ERG and FLI1 protein expression in epithelioid sarcoma

A novel platform for detection of CK+ and CK- CTCs

Targeted Delivery of Small Interfering RNA Using Reconstituted High-Density Lipoprotein Nanoparticles

Clinical behavior of stage II-IV low-grade serous carcinoma of the ovary

Interobserver and intraobserver variability of a two-tier system for grading ovarian serous carcinoma

Biological Roles of the Delta Family Notch Ligand Dll4 in Tumor and Endothelial Cells in Ovarian Cancer

Gross cystic disease fluid protein-15 and mammaglobin A expression determined by immunohistochemistry is of limited utility in triple-negative breast cancer

Undifferentiated carcinoma of the endometrium

HLA Class I Antigen Processing Machinery Component Expression and Intratumoral T-Cell Infiltrate as Independent Prognostic Markers in Ovarian Carcinoma

Immunohistochemical Studies of Trophoblastic Tumors

Thyroid transcription factor-1 expression in ovarian epithelial neoplasms

Overexpression of the Centrosomal Protein Aurora-A Kinase is Associated with Poor Prognosis in Epithelial Ovarian Cancer Patients

Implementation of American Society of Clinical Oncology/College of American Pathologists HER2 Guideline Recommendations in a tertiary care facility increases HER2 immunohistochemistry and fluorescence in situ hybridization concordance and decreases the number of inconclusive cases

PAX2 expression in low malignant potential ovarian tumors and low-grade ovarian serous carcinomas

Galectin-7 levels predict radiation response in squamous cell carcinoma of the cervix

The insulin-like growth factor 1 pathway is a potential therapeutic target for low-grade serous ovarian carcinoma

Mitosis-specific marker phospho-histone H3 in the assessment of mitotic index in uterine smooth muscle tumors: a pilot study

Efficacy of p16 and ProExC Immunostaining in the Detection of High-Grade Cervical Intraepithelial Neoplasia and Cervical Carcinoma

Secondary chondrosarcoma

Genome wide DNA copy number analysis of serous type ovarian carcinomas identifies genetic markers predictive of clinical outcome

Suchergebnisse filtern